Analyst Price Targets — ILMN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 9, 2026 12:01 pm | — | Piper Sandler | $170.00 | $119.72 | TheFly | Illumina price target lowered to $170 from $195 at Piper Sandler |
| February 6, 2026 2:46 pm | Catherine Ramsey Schulte | Robert W. Baird | $137.00 | $120.22 | TheFly | Illumina price target raised to $137 from $132 at Baird |
| February 6, 2026 1:25 pm | — | UBS | $135.00 | $121.27 | TheFly | Illumina price target raised to $135 from $120 at UBS |
| February 6, 2026 1:20 pm | — | Evercore ISI | $150.00 | $121.13 | TheFly | Illumina price target lowered to $150 from $155 at Evercore ISI |
| January 26, 2026 2:35 pm | Subbu Nambi | Guggenheim | $170.00 | $150.38 | TheFly | Illumina price target raised to $170 from $144 at Guggenheim |
| January 26, 2026 11:21 am | — | Canaccord Genuity | $150.00 | $150.28 | TheFly | Illumina price target raised to $150 from $130 at Canaccord |
| January 20, 2026 12:28 pm | Daniel Arias | Stifel Nicolaus | $155.00 | $141.65 | TheFly | Illumina price target raised to $155 from $135 at Stifel |
| January 5, 2026 2:50 pm | Vijay Kumar | Evercore ISI | $155.00 | $138.50 | TheFly | Illumina price target raised to $155 from $142 at Evercore ISI |
| January 5, 2026 2:27 pm | — | Guggenheim | $144.00 | $138.11 | TheFly | Illumina price target raised to $144 from $114 at Guggenheim |
| December 15, 2025 10:55 am | — | Barclays | $110.00 | $134.85 | TheFly | Illumina price target raised to $110 from $100 at Barclays |
Latest News for ILMN
Citigroup Inc. raised its holdings in shares of Illumina, Inc. (NASDAQ: ILMN) by 8.2% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 167,103 shares of the life sciences company's stock after acquiring an additional 12,649 shares during the period.
Increased adoption of clinical whole-genome sequencing is advancing diagnostics for rare diseases, which affect 15 million American children SAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that Illumina Laboratory Services, Illumina's CLIA-certified laboratory, is providing clinical sequencing and interpretation services to the new Diagnostic Lab at Florida Institute for…
In 2026, MedTech players' success will hinge on their ability to balance near-term pressure with long-term transformation. Per a report by ZS, these players must address immediate operational, financial, and regulatory challenges without losing sight of broader industry shifts.
SAN JOSE, Calif.--(BUSINESS WIRE)-- #NGS--Takara Bio USA collaborates with Illumina on a single-cell-resolution spatial mapping workflow, presented at AGBT 2026.
At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions SAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base sequencing, and proteomics technologies. The ability to combine more than one omic insight reveals unprecedented biological depth and…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.